Reid et al. Safety of immune checkpoint inhibitor combo vs mono in pre-existing autoimmune disease. No significant difference. But 59% vs 32% for irAEs and 23% vs 10% for high grade irAEs @RheumNow #ACR22 Abstr#0757 https://t.co/UYhRM4xO9r https://t.co/r4NurxXzGZ
Links:
Safety and Effectiveness of Immune Checkpoint Inhibitors Combination versus Sin…
https://acrabstracts.org/abstract/safety-and-effectiveness-of-immune-checkpoint…
13-11-2022
